Modulation of interleukin-18 expression in human colon carcinoma: Consequences for tumor immune surveillance

International Journal of Cancer

Volumn 84, Issue 3, 1999, Pages 326-330

  Pagès, Franck ^a,b   Berger, Anne ^b   Henglein, Berthold ^a   Piqueras, Bernard ^a   Danel, Claire ^b   Zinzindohoue, Franck ^b   Thiounn, Nicolas ^c   Cugnenc, Paul H ^b   Fridman, Wolf H ^a  

^a INSTITUT CURIE   (France)

^b Hopital Laennec   (France)

^c Université Paris Descartes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 18;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033064554     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990621)84:3<326::AID-IJC22>3.3.CO;2-B     Document Type: Article

References (24)

1. BILLIAU, A., Interferon-gamma: biology and role in pathogenesis. Advanc. Immunol., 62, 61-130 (1996).
2. BOHN, E., SING, A., ZUMBIHL, R., BIELFELDT, C., OKAMURA, H., KURIMOTO, M., HEESEMANN, J. and AUTENRIETH, I.B., IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J. Immunol., 160, 299-307 (1998).
3. FRIDMAN, W.H., BERGER, A., CUGNENC, P.H. and TARTOUR, E., Cytokines as prognostic and therapeutic tools in human cancer. Europ. Cytokine Netw., 8, 321-322 (1997).
4. FUKUMOTO, H., NISHIO, M., NISHIO, K., HEIKE, Y., ARIOKA, H., KUROKA, W.A.H., ISHIDA, T., FUKUOKA, K., NOMOTO, T., OHE, Y. and SAIJO, N., Interferon-gamma-inducing factor gene transfection into Lewis lung carcinoma cells reduces tumorigenicity in vivo. Jap. J. Cancer Res., 88, 501-505 (1997).
5. GHAYUR, T. and 14 OTHERS. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature (Lond.), 386, 619-623 (1997).
6. HUNTER, C.A., TIMANS, J., PISACANE, P., MENON, S., CAI, G., WALKER, W., ASTE-AMEZAGA, M., CHIZZONITE, R., BAZAN, J.F. and KASTELEIN, R.A., Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer. Europ. J. Immunol., 27, 2787-2792 (1997).
7. LUNDQVIST, C., MELGAR, S., YEUNG, M.M., HAMMARSTROM, S. and HAMMARSTROM, M.L., Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions. J. Immunol., 157, 1926-1934 (1996).
8. MATSUSHITA, K., TAKENOUCHI, T., KOBAYASHI, S., HAYASHI, H., OKUYAMA, K., OCHIAI, T., MIKATA, A. and ISONO, K., HLA-DR antigen expression in colorectal carcinomas: influence of expression by IFN-gamma in situ and its association with tumour progression. Br. J. Cancer, 73, 644-648 (1996).
9. MICALLEF, M.J., OHTSUKI, T., KOHNO, K., TANABE, F., USHIO, S., NAMBA, M., TANIMOTO, T., TORIGOE, K., FUJII, M., IKEDA, M., FUKUDA, S. and KURIMOTO, M., Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Europ. J. Immunol., 26, 1647-1651 (1996).
10. MICALLEF, M.J., YOSHIDA, K., KAWAI, S., HANAYA, T., KOHNO, K., ARAI, S., TANIMOTO, T., TORIGOE, K., FUJII, M., IKEDA, M. and KURIMOTO, M., In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites. Cancer Immunol. Immunother., 43, 361-367 (1997).
11. MOLLER, P., KORETZ, K., LEITHAUSER, F., BRUDERLEIN, S., HENNE, C., QUENTMEIER, A. and KRAMMER, P.H., Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer, 57, 371-377 (1994).
12. NAKAMURA, K., OKAMURA, H., WADA, M., NAGATA, K. and TAMURA, T., Endotoxin-induced serum factor that stimulates gamma interferon production. Infect. Immun., 57, 590-595 (1989).
13. O'HARA, R.J., GREENMAN, J., MACDONALD, A.W., GASKELL, K.M., TOPPING, K.P., DUTHIE, G.S., KERIN, M.J., LEE, P.W. and MONSON, J.R., Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin. Cancer Res., 4, 1943-1948 (1998).
14. OSAKI, T., PERON, J.M., CAI, Q., OKAMURA, H., ROBBINS, P.D., KURIMOTO, M., LOTZE, M.T. and TAHARA, H., IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. J. Immunol., 160, 1742-1749 (1998).
15. PARNET, P., GARKA, K.E., BONNERT, T.P., DOWER, S.K. and SIMS, J.E., IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J. Biol. Chem., 271, 3967-3970 (1996).
16. STRATER, J., KORETZ, K., GUNTHERT, A.R. and MOLLER, P., In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. Gut, 37, 819-825 (1995).
17. TAKEUCHI, M., NISHIZAKI, Y., SANO, O., OHTA, T., IKEDA, M. and KURIMOTO, M., Immunohistochemical and immuno-electron-microscopic detection of interferon-gamma-inducing factor ("interleukin-18") in mouse intestinal epithelial cells. Cell Tissue Res., 289, 499-503 (1997).
18. TAN, J., CRUCIAN, B.E., CHANG, A.E., ARUGA, E., ARUGA, A., DOVHEY, S.E., TANIGAWA, K. and YU, H., Interferon-gamma-inducing factor elicits antitumor immunity in association with interferon-gamma production. J. Immunother., 21, 48-55 (1998).
19. TARTOUR, E., GEY, A., SASTRE-GARAU, X., LOMBARD SURIN, I., MOSSERI, V. and FRIDMAN, W.H., Prognostic value of intratumoral interferon gamma messenger RNA. Expression in invasive cervical carcinomas. J. nat. Cancer Inst., 90, 287-294 (1998).
20. TARTOUR, E., GEY, A., SASTRE-GARAU, X., PANNETIER, C., MOSSERI, V., KOURILSKY, P. and FRIDMAN, W.H., Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. Cancer Res., 54, 6243-6248 (1994).
21. THIOUNN, N., PAGES, F., FLAM, T., TARTOUR, E., MOSSERI, V., ZERBIB, M., BEUZEBOC, P., DENEUX, L., FRIDMAN, W.H. and DEBRE, B., IL-6 is a survival prognostic factor in renal cell carcinoma. Immunol. Lett., 58, 121-124 (1997).
22. USHIO, S. and 15 OTHERS, Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol., 156, 4274-4279 (1996).
23. WILSON, J.R., PATEL, P.M., WOOD, A., SELBY, P.J. and JACKSON, A.M., Retroviral gene transfer of IL-18 in vitro. Brit. J. Cancer, 78 (Suppl. 1), 128 (1998).
24. XU, X., FU, X.Y., PLATE, J. and CHONG, A.S., IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for upregulation of Fas and FasL expression. Cancer Res., 58, 2832-2837 (1998).